Zdrowie i gospodarka · 04/11/2004

FDA Announces Opportunity for Public Comment on Iontophoresis Device Reclassification

The FDA is seeking public input on its plan to reclassify iontophoresis devices from class III to class II, which would require less stringent premarket approval and special controls.